Evidence map›Paper›PMID 36189114›Full record

ArticleLancet regional health. Americas2022

Incidence of respiratory virus illness and hospitalizations in a Panama and El Salvador birth cohort, 2014-2018.

Eduardo Azziz-Baumgartner, Lindsey M Duca, Rosalba González, Arlene Calvo, S Cornelia Kaydos-Daniels, Natalie Olson, Adam MacNeil, Vic Veguilla, Rhina Domínguez, Andrea Vicari and 7 more

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Eduardo Azziz-BaumgartnerCenters for Disease Control and Prevention, Atlanta, GA, USA.
Lindsey M DucaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Rosalba GonzálezGorgas Institute, Panama City, Panama.
Arlene CalvoGorgas Institute, Panama City, Panama.
S Cornelia Kaydos-DanielsCenters for Disease Control and Prevention, Atlanta, GA, USA.
Natalie OlsonCenters for Disease Control and Prevention, Atlanta, GA, USA.
Adam MacNeilCenters for Disease Control and Prevention, Atlanta, GA, USA.
Vic VeguillaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Rhina DomínguezNational Institute of Health of El Salvador, El Salvador.
Andrea VicariPan American Health Organization.
Rafael RaudaNational Institute of Health of El Salvador, El Salvador.
Nga VuongCenters for Disease Control and Prevention, Atlanta, GA, USA.
Alba María RoperoPan American Health Organization.
Julio ArmeroNational Institute of Health of El Salvador, El Salvador.
Rachael PorterCenters for Disease Control and Prevention, Atlanta, GA, USA.
Danilo FrancoGorgas Institute, Panama City, Panama.
Juan Miguel PascaleGorgas Institute, Panama City, Panama.
Centers for Disease Control and Prevention · USInstituto Conmemorativo Gorgas de Estudios de la Salud · PAPan American Health Organization (Cuba) · CUFlorida State University-Panama · PA

Funding

NCIRD CDC HHS U01 IP000791
6 · The paper itself

Abstract

Background: Respiratory viruses remain a key cause of early childhood illness, hospitalization, and death globally.The recent pandemic has rekindled interest in the control of respiratory viruses among paediatric populations. We estimate the burden of such viruses among children <2 years. Methods: Enrolled neonates were followed until two years of age. Weekly active symptom monitoring for the development of acute respiratory illnesses (ARI) defined as cough, rhinorrhoea, difficulty breathing, asthenia, anorexia, irritability, or vomiting was conducted. When the child had ARI and fever, nasopharyngeal swabbing was performed, and samples were tested through singleplex RT-PCR. Incidence of respiratory viruses was calculated by dividing the number of laboratory-confirmed detections by the person-time accrued during weeks when that virus was detectable through national surveillance then corrected for under-ascertainment among untested children. Findings: During December 2014-November 2017, 1567 enrolled neonates contributed 2,186.9 person-years (py). Six in ten (64·4%) children developed ARI (total 2493 episodes). Among children <2 years, incidence of respiratory syncytial virus (RSV)-associated ARI episodes (21·0, 95%CI 19·3-22·8, per 100py) and rhinovirus-associated (20·5, 95%CI 20·4-20·7) were similar and higher than parainfluenza 1-3-associated (14·2, 95%CI 12·2-16·1), human metapneumovirus-associated (9·2, 95%CI 7·7-10·8), influenza-associated (5·9, 95%CI 4·4-7·5), and adenovirus-associated ARI episodes (5·1, 95%CI 5·0-5·2). Children aged <3 months had the highest rates of RSV ARI (49·1, 95%CI 44·0-54·1 per 100py) followed by children aged 3-5 (25·1, 95%CI 20·1-30·0), 6-11 (17·6, 95%CI 13·2-21·9), and 12-23 months (11·9, 95%CI 10·8-12·9). One in ten children with RSV was referred to the hospital (2·5, 95%CI 2·1-2·8, per 100py). Interpretation: Children frequently developed viral ARI and a substantive proportion required hospital care. Such findings suggest the importance of exploring the value of new interventions and increasing uptake of existing prevention measures to mitigate burden of epidemic-prone respiratory viruses. Funding: The study was supported by the Centers for Disease Control and Prevention.

Indexed as

Child acute respiratory illnessInfluenzaRespiratory viruses

Identifiers

PMID36189114
PMCPMC9485193
OpenAlexW4283806620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.